SCHEMBL7917474

SCHEMBL7917474

COc1ccc(C(F)(F)F)nc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 15/20 0.43
PDE3A Q14432 2/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PDE4A P27815 5/20 0.38
PDE4C Q08493 5/20 0.38
PDE4D Q08499 5/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30358862 1.00 PDE4B (0.43) PDE4BPDE3APTGS1PTGS2KDM4E
SCHEMBL31525806 0.84 KDM4E (0.33) PDE4BPDE3APTGS1PTGS2KDM4E
SCHEMBL31525713 0.81 HSD11B1 (0.40) PDE4BPTGS1PTGS2KDM4ENPSR1
SCHEMBL31510270 0.80 PTGS1 (0.39) PDE4BPTGS1PTGS2HPGDHTT
SCHEMBL131985 0.79 ADORA2A (0.36) KDM4ELMNAKMT2ASMN1; SMN2ALDH1A1
SCHEMBL30828981 0.79 ADORA2A (0.36) KDM4ELMNAKMT2ASMN1; SMN2ALDH1A1
SCHEMBL20869211 0.78 PDE4B (0.48) PDE4BPDE3APTGS1PTGS2KDM4E
SCHEMBL31525694 0.77 KDM4E (0.33) PDE4BPTGS1PTGS2KDM4EHPGD
SCHEMBL15201463 0.77 ULK1 (0.39) PDE4BPDE3APTGS1PTGS2KDM4E
SCHEMBL31010990 0.77 PDE4B (0.45) PDE4BPDE3APTGS1PTGS2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117651699-A Compounds and compositions for the treatment of coronavirus related diseases 诺华股份有限公司 2024-03-05 CN disclosed
US-6225320-B1 TREATMENT OF PAIN, INFLAMMATION, MIGRAINE, EMESIS AND POSTTHERPETIC NEURALGIA MERCK SHARP & DOHME LTD. (GB) 2001-05-01 US disclosed
EP-0989987-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LTD. (GB) 2000-04-05 EP disclosed
WO-1998054187-A1 SPIRO-AZACYCLIC DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS MERCK SHARP & DOHME LIMITED (GB) 1998-12-03 WO disclosed